| Financial Year |
March 31 2023 |
| Monetary Funds |
816,885,348.27 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,567,364.54 |
| Accounts Receivable |
733,469,123.88 |
| Advances to Suppliers |
70,042,872.90 |
| Other Receivables |
47,436,212.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,489,308,068.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,717,708.60 |
| Total Current Assets |
3,695,283,836.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
136,893,869.95 |
| Long-term Equity Investment |
81,852,665.88 |
| Investment Properties |
-- |
| Fixed Assetes |
6,518,122,201.33 |
| Under-construction Projects |
2,185,408,311.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
356,043,238.94 |
| R&D expenses |
-- |
| Goodwill |
200,604,505.33 |
| Long-Term Deferred and Prepaid Expenses |
1,516,922.38 |
| Deferred Income Tax Assets |
186,112,842.84 |
| Other Non-Current Assets |
32,435,666.25 |
| Sub-Total of Non-Current Assets |
9,698,990,224.55 |
| Total Assets |
13,394,274,061.05 |
| Short-Term Loans |
2,798,027,680.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
436,479,518.37 |
| Accounts Payable |
1,152,926,643.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
44,423,130.48 |
| Taxes Payable |
73,431,374.63 |
| Interest Payable |
-- |
| Dividend Payable |
693,312.52 |
| Other payables |
66,549,156.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
647,322,576.97 |
| Other Current Liabilities |
35,747,717.94 |
| Sub-Total of Current Liabilities |
5,585,372,926.02 |
| Long-term Loans |
1,827,351,330.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,054,491.36 |
| Deferred Income Tax Liabilities |
30,117,040.61 |
| Other Non-Current Liabilities |
115,344,010.81 |
| Sub-Total of Non-Current Liabilities |
2,033,834,253.36 |
| Total Liabilities |
7,619,207,179.38 |
| Paid-In Capital(Or Share Stock) |
993,635,018.00 |
| Capital Surplus |
2,404,758,195.72 |
| Surplus Reserve |
309,020,547.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,860,570,880.96 |
| Minority Stockholder's Interest |
29,017,396.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,746,049,485.52 |
| Owner's Equity（Stockholder's Equity） |
5,775,066,881.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,394,274,061.05 |
